Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01582152
What this trial is testing

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Who this might be right for
Brain NeoplasmsCentral Nervous System Neoplasms
M.D. Anderson Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Testing effectiveness (Phase 2)Study completedNCT02986178
What this trial is testing

Lerapolturev in Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Istari Oncology, Inc. 121
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
University College, London 38
Not applicableLooking for participantsNCT04427384
What this trial is testing

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Who this might be right for
Brain Tumor, RecurrentBrain TumorBrain Tumor, Primary+3 more
GT Medical Technologies, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT00024258
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Testing effectiveness (Phase 2)Study completedNCT02073968
What this trial is testing

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+4 more
Albert Einstein College of Medicine 35
Early research (Phase 1)Study completedNCT02564198
What this trial is testing

Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Who this might be right for
Pediatric Solid TumorRefractory TumorRecurrent Tumor+1 more
Eli Lilly and Company 29
Early research (Phase 1)Looking for participantsNCT05686798
What this trial is testing

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more
Henry Ford Health System 18
Testing effectiveness (Phase 2)Study completedNCT00641706
What this trial is testing

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Ended earlyNCT04239092
What this trial is testing

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Who this might be right for
Refractory CancerRefractory NeoplasmCancer Pediatric+8 more
Actuate Therapeutics Inc. 40
Early research (Phase 1)Study completedNCT00612001
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 8
Not applicableUnknownNCT05868928
What this trial is testing

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Who this might be right for
Brain MetastasesRadiosurgery
Asan Medical Center 132
Early research (Phase 1)Study completedNCT01135563
What this trial is testing

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

Who this might be right for
Solid TumorsCentral Nervous System Tumors
The Hospital for Sick Children 14
Not applicableTemporarily pausedNCT04810871
What this trial is testing

Surgical Resection of Latent Brain Tumors Prior to Recurrence

Who this might be right for
Brain Neoplasm
Mayo Clinic 40
Testing effectiveness (Phase 2)Study completedNCT00047073
What this trial is testing

Sirolimus in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 13
Not applicableUnknownNCT03457389
What this trial is testing

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Who this might be right for
Pituitary AdenomaProlactinomaPituitary Tumor+1 more
Seoul National University Hospital 68
Next Page